Navigation Links
New technique detects specific chromosomal damage, may indicate lung cancer risk
Date:8/31/2007

strategies that might reduce the persisting morbidity and mortality from lung cancer, said Dr. Varella-Garcia.

The researchers found a marked difference between the chromosomal abnormality index (CAI) of never-smokers and that of high-risk smokers and patients with lung cancer.

Theres a tremendous amount of chromosomal damage in smokers who dont yet have cancer, said Dr. Franklin. Chromosomal abnormalities were observed in 82 percent of high-risk smokers and in all patients with carcinoma, regardless of their self-reported tobacco exposure. Patients with cancer and high-risk smokers had nearly 23 and 15 times more chromosomal abnormalities, respectively, than never-smokers.

The most common changes among patients with cancer and high-risk smokers were gains on chromosomes 5, 7, 8 and 18.

The results from SKY were confirmed by fluorescence in situ hybridization (FISH). The FISH technique offers a less comprehensive view of genetic changes, but unlike SKY, can detect genetic changes in interphase cells, which are readily available in sputum samples.

Whereas SKY is not a practical tool to directly apply to sputum, it does identify candidate chromosomal sequences that could improve the sensitivity of a FISH probe set for sputum screening and risk assessment, wrote Dr. Franklin. Improvement in sensitivity and perhaps automated processing and analysis could move a FISH-based assay toward clinical application.

The researchers noted that their pilot study could not affirmatively determine whether the changes were predictive of eventual cancer, but their data point to an important avenue for future research. It will be necessary to study larger cohorts for a longer interval, they wrote, concluding, SKY FISH is a feasible technique for comprehensive evaluation of the chromosomal changes in nonmalignant bronchial epithelial cells of high-risk individuals.


'/>"/>

Contact: Suzy Martin
smartin@thoracic.org
212-315-8631
American Thoracic Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
2. New Laser Techniques cure degeneration of the eye
3. Micro-camera provides new breast imaging technique
4. IVF technique May Increase The Risk Of Birth Defects
5. New Technique For Benign Breast Tumors
6. New technique to diagnose heart disease
7. Novel biopsy technique for prostate cancer
8. New technique for heart enlargement
9. Laser technique assists beard problem
10. Comparing Breast surgery techniques
11. Latest technique for asthma treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...ncer stem cells, seem to be obstinate, as scientis...o radiation therapy. As a result, they are extreme...uld even increase the growth of these stem cells, ...a, Los Angeles, who are the first to have suggeste...
...ring Testosterones can slow down the progression o...nducted on mice. Testosterone, the primary male se...hormones referred to as androgens. The findings,... The Journal of Neuroscience, provide new insight ...
...nister Anbumani Ramadoss Tuesday said the governme...minorities to help curb the polio outbreak in Indi...in the polio immunisation campaigns in Uttar Prade... growth of the disease in the state this year. "W...
... researchers have issued a warning about 'DNA-diet... tall claims of its ability to confront cancer and...rchers at the Economic and Social Research Council... at the University of Exeter, is the first study o...
Other Medicine News:Health News:Increase Testosterone Levels To Slow Down Alzheimer’ 2
(Date:7/23/2008)... Body Have Greater Concentrations of,Stem Cells, ...swire/ -- Fat removed,from the lower abdomen and i...excellent source of stem cells, with higher stem c...eports a Brazilian-based study in August,s,Plastic...al journal of the,American Society of Plastic Surg...
(Date:7/23/2008)...Call/ -- Dendreon Corporation,(Nasdaq: DNDN ) tod...Monitoring Committee (IDMC) to review in October 2...ing to the Company,s Phase 3 IMPACT (IMmunotherapy... as D9902B) clinical trial,of PROVENGE(R) (sipuleu...active cellular immunotherapy for the treatment of...
(Date:7/22/2008)...wswire-FirstCall/ -- Following a,thorough review t...Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) t...phase 3 study in liver cancer. Progen confirmed,it...folio of compounds and,the company will actively s...ies through Merger & Acquisition activity., The s...
(Date:7/22/2008)...-- Nonin Medical, a leading innovator,of physiolog...has entered,the clinical testing phase with its br...aturation. Today,s most common application for thi...egional blood oxygenation,in the brain -- cerebral...an ongoing clinical study at the,Duke University M...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Environmental Toxins Radiation May Be Tied to Breast Cancer 14754 1Environmental Toxins Radiation May Be Tied to Breast Cancer 14754 2Environmental Toxins Radiation May Be Tied to Breast Cancer 14754 3Environmental Toxins Radiation May Be Tied to Breast Cancer 14754 4Ancient lemurs little finger poses mystery 2551 1Ancient lemurs little finger poses mystery 2551 2Senior Obama Strategist David Axelrod and Wife Susan to be Honored for Their Decade Long Commitment to Epilepsy Research at NYC Benefit 14750 1Senior Obama Strategist David Axelrod and Wife Susan to be Honored for Their Decade Long Commitment to Epilepsy Research at NYC Benefit 14750 2Columbia University Medical Center NYPH receive 2428 million donation toward curing diabetes 14747 1Columbia University Medical Center NYPH receive 2428 million donation toward curing diabetes 14747 2Columbia University Medical Center NYPH receive 2428 million donation toward curing diabetes 14747 3
GENTAMICIN SULFATE, 1000X
Gentamicin is a selection antibiotic used for selection of a Bac-to-Bac recombinant expression bacmid following transposition. Gentamicin is provided as a solution at a concentration of 50 mg/ml.
1.0% Tryptone, 0.5% yeast extract, 0.5% Sodium Chloride, 1.5% agarose.
1% tryptone, 0.5% yeast extract, 1.0% Sodium Chloride, 1.5% agar.
Medicine Products: